Clinical comparison · Metabolic
MOTS-c vs 5-Amino-1MQ
MOTS-c is an injected mitochondrial peptide activating AMPK. 5-Amino-1MQ is an oral small molecule restoring adipocyte NAD+ metabolism.
Attribute
MOTS-c
5-Amino-1MQ
Mechanism
Mitochondrial-derived peptide; enhances glucose disposal and metabolic flexibility via AMPK activation.
Small-molecule NNMT inhibitor. Restores NAD+/SAM pool, increases adipocyte metabolic activity.
Standard dosing
5–10 mg SC 2–3x weekly in 4–8 week cycles.
50–150 mg orally daily.
Indications
- Metabolic health
- Insulin sensitivity
- Exercise capacity
- Body composition
- Metabolic health
- Adjunct to GLP-1 or GH programs
Strengths
- Mitochondrial-level intervention
- Complements GLP-1 programs
- Oral dosing
- Non-hormonal metabolic lever
- Preserves lean mass
Cautions
- Emerging clinical evidence
- Cycled, not continuous
- Emerging clinical evidence
- Not a standalone weight-loss agent
Choose MOTS-c when
Patient will accept SC injections for metabolic-flexibility programs.
Wholesale MOTS-c →Choose 5-Amino-1MQ when
Patient prefers oral dosing or is already on multiple injectables.
Wholesale 5-Amino-1MQ →FAQs
- Can they be stacked?
- Yes. Mechanisms are complementary and non-overlapping — both fit into a GLP-1 metabolic program.
- Which is more established?
- MOTS-c has more mechanistic literature; both remain emerging clinically.